BSECompany Update9 Oct 2026 · 9 Oct 2026, 11:18 am

Compliance under Reg 74(5) of SEBI (DP) regulations.

Venus Remedies Ltd · 526953

✦ AI Summary

Venus Remedies Ltd has filed a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities and listing of securities on stock exchanges.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Venus Remedies Ltd - 526953 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Attachments (1)

📄

341afa8a-553c-433b-a49f-8ccefdbf6937.pdf

pdf

Download →
View document text
VENUS 6nioy g nnoualions VRL/SEC/EXCHANGE 09.10.2026 National Stock Exchange of India BSE Limited Ltd. 25th Floor, Phiprinceroze Jeejeebhoy 5th Floor, Exchange Plaza Towers, Dalal Street Bandra (E), Mumbai Mumbai- 400 051 Script Code: 526953 Script Code: VENUSREM Sub.: Compliance under Regulatjon74(5) of SEBl (Depositories and Participants) Regulations.2018. Dear Sir/ Madam, In compliance with Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulation, 2018, we enclose herewith Confirmation Certificate received from our Registrar & Transfer Agent, M/s MUFG lntime India Pvt Ltd. for the quarter ended on 30th September 2026. Thanking you Yours faithfully, for VENUS REMEDIES LIMITED Neha (Company Secretary) M. No. F8374 VENUS REMEDIES LIMITED Corponte Omc. : Uult-I : 51 -52, Industrial Area, Phase-I, Panchkula (Hry.) i:i-.5.2;5T9]u7S2r233t886?gssc3'6'9ETFC±ku+[gfT]72)_23€;!3'6'nd`a 1341 13 , India Reed. once : Ualt-II : SCO 857, Cabin No. 10, 2nd Floor, NAG, Manimajra, Chandigarh (U.T.) 160101, India ¥ei;i°I##9S':g294d28isi#;;2f?¥oa!:]E:::'Phase'HExtn.) Website . www.venusremedies.com www.vmrcindia.com Uult-V : VENUS PHARMA GmbH ©#"ETgs en¥JL2¥ffiENfse8EL€tw7o5 AM Bahnhof 1-3, D-59368, Weme, Germany ©MUFG MUFC Intlm. lhdl. P.lv.I. Llrnltnd (Formerly Lirik lntimo India Private Lini(ed) ciN: ue7icoNHie.9pTci ie3ce Noble Hoight§. 1 8t toor, Plot No NH-2, C.1 Block. LSC. N®ai S®vtm Mark®t. Janakpuri. Nour Delhi -11cO58. T.I: +91 11 4941 1000 vw.in.mpm8.mufg.com Octofror 7, 2o26 The Company Secrofary Venue Ronedles llmltod SCO e57, cABiN NO io , 2NO FLOOR, MAC, MANIMAJRA Chandl8arh -160101. Dear Sir. ?_|irm caTqurm e!rftqu led:r Ft.au+.tlon 74(!\ Of amrftha .nd E]tchmn ~_Of d Partlc ln reference to the above captioned regulation. we hereby confirm that the securities received from the depository participants for dematerialization during the qiiarter ended 3On September 2026, were confirmed (accepted/rejected) to the depositories by us and that securities comprised in the said certificates have been listed on the stock exchanges where the earlier issued secu ties are listed. ve hereby also confirm that the §®curity certificates received for dematerialisation have been confined/rejected and the security certificates received were mutilated and cancelled after due verificatl.on by the depository participant and the name of the depositories have bcon substituted in the register of members as the registered owner within the prescribed timoljnes. We request you to kindly take note of the above in your records. Thanklng You, Youn falthfully. Foi MUFG Intlm® lndla Prlv.t® Llmlt®d (Fomerly Llnk lntlme India Private Llmlt®d) . .i._.' -.-- i -. Swapan Kr Nas Asooclate Vi a Head (Delhl Branch) MUFG Intlme lndl. PTlvat. umked A part of MUFG Corporate Markets, 3 division of MUFG Pension & Market Services